Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Cancer Biopsy Market Outlook (2023 to 2033)

Newly-released Cancer Biopsy Market analysis report by Future Market Insights shows that global sales of the Cancer Biopsy Market in 2022 were held at US$ 22.2 Billion. With a CAGR of 18%, the projected market growth from 2023 to 2033 is expected to be higher than the historical growth. The Tissue Biopsies type is expected to be the highest revenue-generating segment, accounting for a CAGR of nearly 19% from 2023 to 2033.

Attribute Details
Global Cancer Biopsy Market (2023) US$ 25.5 Billion
Global Cancer Biopsy Market (2033) US$ 131.4 Billion
Global Cancer Biopsy Market CAGR (2023 to 2033) 18%
USA Cancer Biopsy Market CAGR (2023 to 2033) 21.4%
Key Companies Profiled
  • Qiagen N.V.
  • Illumina, Inc.
  • ANGLE Plc
  • Becton, Dickinson, and Company
  • Myriad Genetics
  • Hologic, Inc.
  • Biocept, Inc.
  • Thermo Fisher Scientific, Inc.
  • Danaher
  • F. Hoffmann-La Roche Ltd.
  • Lucence Diagnostics Pte. Ltd.
  • GRAIL, Inc.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue of Cancer Biopsy Market from 2018 to 2022 Compared to Demand Outlook for 2023 to 2033

As per the Cancer Biopsy Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value increased at around 13.9% CAGR, wherein, countries such as the USA, United Kingdom, China, Japan, and South Korea held a significant share in the global market.

The increasing elderly populace, along with the rise in instances of cancer diagnoses, is fueling growth in the cancer clinical market. Also, the effective and less costly use of liquid biopsy procedures and increasing biopsy appointees are all expected to impact the market growth.

Some of today's prominent procedures in medical diagnosis include endoscopic, arthroscopic, bone marrow, skin, needle, and surgical biopsies. Needle biopsies are regarded as a trusted method for the early detection of patients suffering from these methods. However, fine-needle aspiration needle biopsies, which have been found to be less invasive and faster, are aiding the increase in popularity of the slice.

What are the key drivers of the Cancer Biopsy Market?

People have much higher rates of cancer nowadays not just because of medical problems like blood pressure and substance abuse, but also because of environmental causes, use of tobacco, biological irrevocable factors, and changes in lifestyle. Cancer is the second biggest cause of death worldwide as a result of contagious viral agents, chemical exposures, toxins, poor environmental factors, substance abuse, and lifestyle choices.

The IARC estimates that by 2020 the worldwide burden of disease due to cancer is projected to be 19.3 million cases and 9.96 million deaths worldwide. A liquid biopsy entails reduced expense, earlier prognosis, therapy surveillance, identification of tumor heterogeneity, acquired drug resistance, and patient comfort compared to conventional diagnostic tools for handling cancer.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Which Region is Projected to Offer the Most Promising Opportunity for Cancer Biopsy Market?

During the forecast period, the market in North America is projected to account for a significant share, with the USA playing a large role in regional revenue. Consequently, effective methods that the US government and its agencies have found are extensively used, permitting liquid biopsies to be developed for use in new states across the nation.

The FDA for quick-sampling practices implements regulatory strategies based on the USA. The recommendations and the approval precedents for specially generated biomarkers, companion diagnostics, and provisional categories of fit under this framework are steps toward the completion of the CLIA-related advancement of liquid biopsy regulatory channels. The incremental success of FDA approval for the Clinical Laboratory Improvement Amendment (CLIA) has included the advancement of liquid biopsy regulatory channels.

With the growing number of breast cancer patients in Asia-Pacific, increased awareness of breast cancer liquid biopsy procedures, growth in the area of in-depth research and development in breast cancer testing, and improved health-related policies as well as the adoption of breast cancer liquid biopsy, companies are seeing lucrative opportunities for their presence in the region.

Breast cancer liquid biopsy reagent kits have the highest demand and are increasingly seen as less invasive. Market growth is also being driven by manufacturers' business development efforts in emerging economies, including in Asia-Pacific, where they are attempting to achieve a higher share of the world's fugitive liquid biopsy product market.

Biotech businesses in South Korea market cancer DNA biopsy, which allows for early detection, precise treatment, and prognostic evaluation. In the future, the market is planning to depend more on genetic mutations that lead to cancer. Growth in this sector is contingent on raising the popularity of such businesses. In the future term, client interactions and fresh research are likely to fuel market expansion.

Country-wise Analysis

USA Cancer Biopsy Market Analysis

The market in the USA is expected to reach a market size of US$ 57 Million by 2033. The market in the country is expected to swell at a CAGR of 21.4% from 2023 to 2033, with an absolute dollar opportunity of US$ 49 Million.

United Kingdom Cancer Biopsy Market Analysis

The market in the United Kingdom is expected to reach a valuation of US$ 4.1 Billion by 2033. Growing with a CAGR of 15.7% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of US$ 3.1 Billion.

Japan Cancer Biopsy Market Analysis

In Japan, the market is expected to grow at a CAGR of 19.4% from 2023 to 2033, reaching US$ 6.2 Billion by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 5.1 Billion during the forecast period.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Why Tissue Biopsies are expected to Garner Significant Growth in Cancer Biopsy Market?

Tissue biopsies are still regarded as a mainstay of biopsies and are widely used in cancer diagnosis applications. The rigorous research procedures that assisted the progression of this market can be attributed to the effective testing of its products.

Advancements aimed at improving tissue biopsy processes are projected to keep the tissue biopsy segment in the lead over the next few years. Cernostics, for example, is working on an assay that can be used to diagnose cancer patients with Barrett's Esophagus.

This one-of-a-kind diagnostic test uses digitally scanned biopsy pictures to aid in the identification and quantification of changes occurring at the cellular or molecular level within a tissue. The tissue biopsies segmental market is expected to develop due to increased acceptance of this form of biopsy due to its high accuracy and low risk of harm.

What are the insights about the Applications of the Cancer Biopsy Market?

According to USA breast cancer statistics, about one in every eight women in the USA develops invasive breast cancer. Year the USA in 2020, an estimated 276,480 new instances of invasive breast cancer will be identified in women, with more than 40,000 new cases of non-invasive breast cancer.

Microscopic analysis of breast tissue is necessary to diagnose cancer or ascertain the tone and type, which is happening more due to the rise in diagnoses. Thanks to the increase in individuals with cancer, the need for needle or surgical biopsies to acquire tissue for analysis has increased, contributing to market growth.

Competitive Analysis

Key companies are helping to drive market expansion by diversifying their diagnostics portfolios and increasing the adoption of their own biopsy tools.

Key recent developments of key players in the Cancer Biopsy Market are as follows:

  • In March 2021, in Russia, KIllumina, Inc. received medical device approval for their NextSeq 550Dx platform and related reagent kits. Prior to this registration, the MiSeq Dx had already been approved as a medical device.
  • In March 2021, Autopsy with Quick-Core IZI Medical Products introduced a system for soft tissue biopsy procedures. This fully automated production is based on Quick-Core, the company's patented semi-automatic method. ?

Similarly, recent developments related to companies in the Cancer Biopsy Market have been tracked by the team at Future Market Insights, which are available in the full report.

Market Segments Covered in Cancer Biopsy Industry Analysis

By Type:

  • Tissue Biopsies
    • Needle Biopsies
    • Surgical Biopsies
  • Liquid Biopsies
  • Other Types

By Product Type:

  • Instruments
  • Kits and Consumables
  • Services

By Application:

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Liver Cancers
  • Pancreatic Cancers
  • Ovarian Cancers
  • Other Applications

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Cancer Biopsy Market?

The market is valued at US$ 25.5 billion in 2023.

What is the Growth Potential of the Cancer Biopsy Market?

The growth potential of the cancer biopsy market is 18% CAGR through 2033.

How Big will be the Cancer Biopsy Market by 2033?

The market is estimated to reach US$ 131.4 billion by 2033.

What is the Growth Potential of the United States market?

The United States market is expected to expand at a CAGR of 21.4% through 2033.

Which Type is Expected to Find Higher Applications?

Tissue biopsies are expected to find greater applications in cancer diagnosis.

Table of Content

1. Executive Summary |Cancer Biopsy Market

    1.1. Global Market Outlook

    1.2. Summary of Statistics

    1.3. Key Market Characteristics & Attributes

    1.4. Future Market Insights Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Risks and Trends Assessment

    3.1. Risk Assessment

        3.1.1. COVID-19 Crisis and Impact

        3.1.2. COVID-19 Impact Benchmark with Previous Crisis

        3.1.3. Impact on Market Value (US$ Billion)

        3.1.4. Assessment by Key Countries

        3.1.5. Assessment by Key Market Segments

        3.1.6. Action Points and Recommendation for Suppliers

    3.2. Key Trends Impacting the Market

    3.3. Formulation and Product Development Trends

4. Market Background

    4.1. Market, by Key Countries

    4.2. Market Opportunity Assessment (US$ Billion)

        4.2.1. Total Available Market

        4.2.2. Serviceable Addressable Market

        4.2.3. Serviceable Obtainable Market

    4.3. Market Scenario Forecast

        4.3.1. Demand in optimistic Scenario

        4.3.2. Demand in Likely Scenario

        4.3.3. Demand in Conservative Scenario

    4.4. Investment Feasibility Analysis

        4.4.1. Investment in Established Markets

            4.4.1.1. In Short Term

            4.4.1.2. In Long Term

        4.4.2. Investment in Emerging Markets

            4.4.2.1. In Short Term

            4.4.2.2. In Long Term

    4.5. Forecast Factors - Relevance & Impact

        4.5.1. Top Companies Historical Growth

        4.5.2. Growth in Automation, By Country

        4.5.3. Patch Management Adoption Rate, By Country

    4.6. Market Dynamics

        4.6.1. Market Driving Factors and Impact Assessment

        4.6.2. Prominent Market Challenges and Impact Assessment

        4.6.3. Patch Management Market Opportunities

        4.6.4. Prominent Trends in the Global Market & Their Impact Assessment

5. Key Success Factors

    5.1. Manufacturers’ Focus on Low Penetration High Growth Markets

    5.2. Banking on with Segments High Incremental Opportunity

    5.3. Peer Benchmarking

6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033

    6.1. Historical Market Analysis, 2018 to 2022

    6.2. Current and Future Market Projections, 2023 to 2033

    6.3. Y-o-Y Growth Trend Analysis

7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033

    7.1. Historical Market Value (US$ Billion) Analysis, 2018 to 2022

    7.2. Current and Future Market Value (US$ Billion) Projections, 2023 to 2033

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Billion) Analysis By Type, 2018 to 2022

    8.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Type, 2023 to 2033

        8.3.1. Tissue Biopsies

            8.3.1.1. Needle Biopsies

            8.3.1.2. Surgical Biopsies

        8.3.2. Liquid Biopsies

        8.3.3. Other Types

    8.4. Market Attractiveness Analysis By Type

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Billion) Analysis By Product Type, 2018 to 2022

    9.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Product Type, 2023 to 2033

        9.3.1. Instruments

        9.3.2. Kits and Consumables

        9.3.3. Services

    9.4. Market Attractiveness Analysis By Product Type

10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Billion) Analysis By Application, 2018 to 2022

    10.3. Current and Future Market Size (US$ Billion) Analysis and Forecast By Application, 2023 to 2033

        10.3.1. Software

        10.3.2. Services

        10.3.3. Cervical Cancers

        10.3.4. Training and Education Services

        10.3.5. Prostate Cancers

        10.3.6. Blood Cancers

        10.3.7. Skin Cancers

        10.3.8. Kidney Cancers

        10.3.9. Liver Cancers

        10.3.10. Pancreatic Cancers

        10.3.11. Ovarian Cancers

        10.3.12. Other Applications

    10.4. Market Attractiveness Analysis By Application

11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Billion) Analysis By Region, 2018 to 2022

    11.3. Current Market Size (US$ Billion) & Analysis and Forecast By Region, 2023 to 2033

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. Asia Pacific

        11.3.5. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.4. Market Size (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033

        12.4.1. By Country

            12.4.1.1. United States of America

            12.4.1.2. Canada

            12.4.1.3. Rest of North America

        12.4.2. By Type

        12.4.3. By Application

        12.4.4. By Product Type

    12.5. Market Attractiveness Analysis

        12.5.1. By Country

        12.5.2. By Type

        12.5.3. By Application

        12.5.4. By Product Type

13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.4. Market Size (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Rest of Latin America

        13.4.2. By Type

        13.4.3. By Application

        13.4.4. By Product Type

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Type

        13.5.3. By Application

        13.5.4. By Product Type

14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.4. Market Size (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. France

            14.4.1.3. United Kingdom

            14.4.1.4. Italy

            14.4.1.5. Spain

            14.4.1.6. Netherlands

            14.4.1.7. Rest of Europe

        14.4.2. By Type

        14.4.3. By Application

        14.4.4. By Product Type

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Type

        14.5.3. By Application

        14.5.4. By Product Type

15. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.4. Market Size (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

            15.4.1.4. Rest of Asia Pacific

        15.4.2. By Type

        15.4.3. By Application

        15.4.4. By Product Type

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Type

        15.5.3. By Application

        15.5.4. By Product Type

16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Billion) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.4. Market Size (US$ Billion) & Forecast By Market Taxonomy, 2023 to 2033

        16.4.1. By Country

            16.4.1.1. Saudi Arabia

            16.4.1.2. South Africa

            16.4.1.3. UAE

            16.4.1.4. Rest of Middle East and Africa

        16.4.2. By Type

        16.4.3. By Application

        16.4.4. By Product Type

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Type

        16.5.3. By Application

        16.5.4. By Product Type

17. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033

    17.1. Introduction

        17.1.1. Market Value Proportion Analysis, By Key Countries

        17.1.2. Global Vs. Country Growth Comparison

    17.2. USA Market Analysis

        17.2.1. Value Proportion Analysis by Market Taxonomy

        17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.2.2.1. By Type

            17.2.2.2. By Application

            17.2.2.3. By Product Type

    17.3. Canada Market Analysis

        17.3.1. Value Proportion Analysis by Market Taxonomy

        17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.3.2.1. By Type

            17.3.2.2. By Application

            17.3.2.3. By Product Type

    17.4. Mexico Market Analysis

        17.4.1. Value Proportion Analysis by Market Taxonomy

        17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.4.2.1. By Type

            17.4.2.2. By Application

            17.4.2.3. By Product Type

    17.5. Brazil Market Analysis

        17.5.1. Value Proportion Analysis by Market Taxonomy

        17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.5.2.1. By Type

            17.5.2.2. By Application

            17.5.2.3. By Product Type

    17.6. Germany Market Analysis

        17.6.1. Value Proportion Analysis by Market Taxonomy

        17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.6.2.1. By Type

            17.6.2.2. By Application

            17.6.2.3. By Product Type

    17.7. France Market Analysis

        17.7.1. Value Proportion Analysis by Market Taxonomy

        17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.7.2.1. By Type

            17.7.2.2. By Application

            17.7.2.3. By Product Type

    17.8. Italy Market Analysis

        17.8.1. Value Proportion Analysis by Market Taxonomy

        17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.8.2.1. By Type

            17.8.2.2. By Application

            17.8.2.3. By Product Type

    17.9. Spain Market Analysis

        17.9.1. Value Proportion Analysis by Market Taxonomy

        17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.9.2.1. By Type

            17.9.2.2. By Application

            17.9.2.3. By Product Type

    17.10. United Kingdom Market Analysis

        17.10.1. Value Proportion Analysis by Market Taxonomy

        17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.10.2.1. By Type

            17.10.2.2. By Application

            17.10.2.3. By Product Type

    17.11. Netherlands Market Analysis

        17.11.1. Value Proportion Analysis by Market Taxonomy

        17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.11.2.1. By Type

            17.11.2.2. By Application

            17.11.2.3. By Product Type

    17.12. China Market Analysis

        17.12.1. Value Proportion Analysis by Market Taxonomy

        17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.12.2.1. By Type

            17.12.2.2. By Application

            17.12.2.3. By Product Type

    17.13. Japan Market Analysis

        17.13.1. Value Proportion Analysis by Market Taxonomy

        17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.13.2.1. By Type

            17.13.2.2. By Application

            17.13.2.3. By Product Type

    17.14. South Korea Market Analysis

        17.14.1. Value Proportion Analysis by Market Taxonomy

        17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.14.2.1. By Type

            17.14.2.2. By Application

            17.14.2.3. By Product Type

    17.15. Saudi Arabia Market Analysis

        17.15.1. Value Proportion Analysis by Market Taxonomy

        17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.15.2.1. By Type

            17.15.2.2. By Application

            17.15.2.3. By Product Type

    17.16. South Africa Market Analysis

        17.16.1. Value Proportion Analysis by Market Taxonomy

        17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.16.2.1. By Type

            17.16.2.2. By Application

            17.16.2.3. By Product Type

    17.17. UAE Market Analysis

        17.17.1. Value Proportion Analysis by Market Taxonomy

        17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033

            17.17.2.1. By Type

            17.17.2.2. By Application

            17.17.2.3. By Product Type

        17.17.3. Competition Landscape and Player Concentration in the Country

18. Market Structure Analysis

    18.1. Market Analysis by Tier of Companies

    18.2. Market Concentration

    18.3. Market Share Analysis of Top Players

    18.4. Market Presence Analysis

        18.4.1. By Regional footprint of Players

        18.4.2. Product footprint by Players

19. Competition Analysis

    19.1. Competition Dashboard

    19.2. Competition Benchmarking

    19.3. Competition Deep Dive

        19.3.1. Qiagen N.V.

            19.3.1.1. Overview

            19.3.1.2. Product Portfolio

            19.3.1.3. Sales Footprint

            19.3.1.4. Strategy Overview

        19.3.2. Illumina, Inc.

            19.3.2.1. Overview

            19.3.2.2. Product Portfolio

            19.3.2.3. Sales Footprint

            19.3.2.4. Strategy Overview

        19.3.3. ANGLE Plc

            19.3.3.1. Overview

            19.3.3.2. Product Portfolio

            19.3.3.3. Sales Footprint

            19.3.3.4. Strategy Overview

        19.3.4. Becton, Dickinson, and Company

            19.3.4.1. Overview

            19.3.4.2. Product Portfolio

            19.3.4.3. Sales Footprint

            19.3.4.4. Strategy Overview

        19.3.5. Myriad Genetics

            19.3.5.1. Overview

            19.3.5.2. Product Portfolio

            19.3.5.3. Sales Footprint

            19.3.5.4. Strategy Overview

        19.3.6. Hologic, Inc.

            19.3.6.1. Overview

            19.3.6.2. Product Portfolio

            19.3.6.3. Sales Footprint

            19.3.6.4. Strategy Overview

        19.3.7. Biocept, Inc.

            19.3.7.1. Overview

            19.3.7.2. Product Portfolio

            19.3.7.3. Sales Footprint

            19.3.7.4. Strategy Overview

        19.3.8. Thermo Fisher Scientific, Inc.

            19.3.8.1. Overview

            19.3.8.2. Product Portfolio

            19.3.8.3. Sales Footprint

            19.3.8.4. Strategy Overview

        19.3.9. Danaher

            19.3.9.1. Overview

            19.3.9.2. Product Portfolio

            19.3.9.3. Sales Footprint

            19.3.9.4. Strategy Overview

        19.3.10. F. Hoffmann-La Roche Ltd.

            19.3.10.1. Overview

            19.3.10.2. Product Portfolio

            19.3.10.3. Sales Footprint

            19.3.10.4. Strategy Overview

        19.3.11. Lucence Diagnostics Pte. Ltd.

            19.3.11.1. Overview

            19.3.11.2. Product Portfolio

            19.3.11.3. Sales Footprint

            19.3.11.4. Strategy Overview

        19.3.12. GRAIL, Inc.

            19.3.12.1. Overview

            19.3.12.2. Product Portfolio

            19.3.12.3. Sales Footprint

            19.3.12.4. Strategy Overview

20. Assumptions and Acronyms Used

21. Research Methodology

Recommendations

Healthcare

Liquid Biopsy Market

Published : October 2023

Healthcare

Breast Cancer Drug Market

Published : July 2023

Healthcare

Lung Cancer Surgery Market

Published : June 2022

Explore Healthcare Insights

View Reports